Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brain.
Sedvall
C G
CG
Karolinska Institute, Stockholm.
Farde
L
L
Hall
H
H
Halldin
C
C
Karlsson
P
P
Brene
S
S
Lindefors
N
N
Persson
H
H
Chipkin
R E
RE
Ehrlich
M
M
D001921:Brain / Q000000981:diagnostic imaging*; D001923:Brain Chemistry / Q000502:physiology; D002540:Cerebral Cortex / Q000000981:diagnostic imaging / Q000378:metabolism; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D006801:Humans; D008024:Ligands; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D010750:Phosphoproteins; D011699:Putamen / Q000000981:diagnostic imaging / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis*; D011954:Receptors, Dopamine / Q000187:drug effects*; D017447:Receptors, Dopamine D1; D014055:Tomography, Emission-Computed
D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D008024:Ligands; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins; D012333:RNA, Messenger; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1